ATC Group: C01DA02 Glyceryl trinitrate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C01DA02 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C01 Cardiac therapy
3 C01D Vasodilators used in cardiac diseases
4 C01DA Organic nitrates
5 C01DA02 Glyceryl trinitrate

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
ORAL Oral 5 mg
SL Sublingual 2.5 mg
T-DERMAL Transdermal 5 mg

Active ingredients in C01DA02

Active Ingredient

Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache.

Related product monographs

Document Type Information Source  
 DEPONIT Transdermal patch MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DERMATRANS Transdermal patch MPI, EU: SmPC Health Products Regulatory Authority (IE)
 GLYTRIN Sublingual spray, solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 NITRO-DUR Transdermal patch MPI, US: SPL/Old FDA, National Drug Code (US)
 NITROCINE Solution for infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)
 NITRODERM TTS Transdermal patch MPI, EU: SmPC Υπουργείο Υγείας (CY)
 NITROLINGUAL Sublingual spray MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 NITRONAL Solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 RECTOGESIC Rectal ointment MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TRANSIDERM NITRO Transdermal patch MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

United States medicines

Medicines classified under this ATC code globally

Australia (AU)

Austria (AT)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.